Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.
Article
CAS
Google Scholar
Joko-Fru WY, Miranda-Filho A, Soerjomataram I, Egue M, Akele-Akpo MT, N’da G, et al. Breast cancer survival in sub-Saharan Africa by age, stage at diagnosis and human development index: A population-based registry study. Int J Cancer. 2020;146(5):1208–18.
Article
CAS
Google Scholar
McCormack V, McKenzie F, Foerster M, Zietsman A, Galukande M, Adisa C, et al. Breast cancer survival and survival gap apportionment in sub-Saharan Africa (ABC-DO): a prospective cohort study. Lancet Glob Heal [Internet]. 2020 1 [cited 2021 Jan 9];8(9):e1203–12. Available from: www.thelancet.com/lancetgh
Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Piñeros M, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53.
Article
CAS
Google Scholar
Sayed S, Moloo Z, Ngugi A, Allidina A, Ndumia R, Mutuiri A, et al. Breast camps for awareness and early diagnosis of breast cancer in countries with limited resources: A multidisciplinary model from Kenya. Oncologist [Internet]. 2016;21(9):1138–48 Available from: https://onlinelibrary.wiley.com/doi/abs/10.1634/theoncologist.2016-0004.
Article
Google Scholar
Knaul FM, Bhadelia A, Gralow J, Arreola-ornelas H, Langer A, Frenk J. Meeting the emerging challenge of breast and cervical cancer in low- and middle-income countries. Int J Gynecol Obstet. 2012;119:S85–8.
Article
Google Scholar
Eng A, McCormack V, dos Santos Silva I. Receptor-Defined Subtypes of Breast Cancer in Indigenous Populations in Africa: A Systematic Review and Meta-Analysis. PLoS Med [Internet]. 2014 1 [cited 2021 Jan 9];11(9). Available from: https://pubmed.ncbi.nlm.nih.gov/25202974/
Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, et al. Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev [Internet]. 2007 Mar [cited 2021 Jan 19];16(3):439–43. Available from: https://pubmed.ncbi.nlm.nih.gov/17372238/
Martínez ME, Cruz GI, Brewster AM, Bondy ML, Thompson PA. What can we learn about disease etiology from case-case analyses? Lessons from breast cancer [Internet]. Vol. 19, Cancer Epidemiology Biomarkers and Prevention. Cancer Epidemiol Biomarkers Prev; 2010 [cited 2021 Feb 20]. p. 2710–4. Available from: https://pubmed.ncbi.nlm.nih.gov/20870734/
Wang S, Ogundiran T, Ademola A, Olayiwola OA, Adeoye A, Sofoluwe A, et al. Development of a breast cancer risk prediction model for women in Nigeria. Cancer Epidemiol Biomarkers Prev [Internet]. 2018 1 [cited 2021 Jan 9];27(6):636–43. Available from: https://pubmed.ncbi.nlm.nih.gov/29678902/
Tishkoff SA, Reed FA, Friedlaender FR, Ranciaro A, Froment A, Hirbo JB, et al. The Genetic Structure and History of Africans and African Americans. 2010;324(5930):1035–44.
Google Scholar
Sayed S, Moloo Z, Wasike R, Bird P, Oigara R, Govender D, et al. Is breast cancer from Sub Saharan Africa truly receptor poor ? Prevalence of ER / PR / HER2 in breast cancer from Kenya. The Breast [Internet]. 2014;23(5):1–6 Available from: https://doi.org/10.1016/j.breast.2014.06.006.
Google Scholar
Sayed S, Moloo Z, Wasike R, Bird P, Oigara R, Njoroge FW, et al. Ethnicity and breast cancer characteristics in Kenya. Breast Cancer Res Treat. 2018;167(2):425–37.
Article
Google Scholar
Wolff AC, McShane LM, Hammond MEH, Allison KH, Fitzgibbons P, Press MF, et al. Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update [Internet]. Vol. 142, Archives of Pathology and Laboratory Medicine. College of American Pathologists; 2018 [cited 2021 Jan 30]. p. 1364–82. Available from: https://pubmed.ncbi.nlm.nih.gov/29846104/
Harbeck N, Thomssen C, Gnant M. St. Gallen 2013: Brief preliminary summary of the consensus discussion. Breast Care. 2013;8(2):102–9.
Article
Google Scholar
Bustreo S, Osella-Abate S, Cassoni P, Donadio M, Airoldi M, Pedani F, et al. Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up. Breast Cancer Res Treat. 2016;157(2):363–71.
Article
CAS
Google Scholar
Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thürlimann B, Senn HJ. Strategies for subtypes-dealing with the diversity of breast cancer: Highlights of the St Gallen international expert consensus on the primary therapy of early breast cancer 2011. Ann Oncol. 2011;22(8):1736–47.
Article
CAS
Google Scholar
Maisonneuve P, Disalvatore D, Rotmensz N, Curigliano G, Colleoni M, Dellapasqua S, et al. Proposed new clinicopathological surrogate definitions of luminal A and luminal B (HER2-negative) intrinsic breast cancer subtypes. Breast Cancer Res. 2014;16(3):R65.
Article
Google Scholar
Figueroa JD, Davis Lynn BC, Edusei L, Titiloye N, Adjei E, Clegg-Lamptey JN, et al. Reproductive factors and risk of breast cancer by tumor subtypes among Ghanaian women: A population-based case–control study. Int J Cancer. 2020;147(6):1535–47.
Article
CAS
Google Scholar
Palmer JR, Boggs DA, Wise LA, Ambrosone CB, Adams-Campbell LL, Rosenberg L. Parity and Lactation in Relation to Estrogen Receptor Negative Breast Cancer in African American Women. Cancer Epidemiol Biomarkers Prev. 2011;20(9):1883–91.
Article
CAS
Google Scholar
Palmer JR, Viscidi E, Troester MA, Hong CC, Schedin P, Bethea TN, et al. Parity, lactation, and breast cancer subtypes in African American Women: Results from the AMBER Consortium. J Natl Cancer Inst [Internet]. 2014 [cited 2020 Sep 13];106(10).
Bandera EV, Chandran U, Hong C, Melissa A, Traci N, Lucile L, et al. Obesity, bodyfat distribution,and riskof breast cancer subtypes in African American women participating in the AMBER consortium. Curr Drug Targets Immune Endocr Metabol Disord. 2016;150(3):655–66.
Google Scholar
Ambrosone CB, Zirpoli G, Hong CC, Yao S, Troester M, Bandera E, et al. Important Role of Menarche in Development of Estrogen Receptor-Negative Breast Cancer in African American Women. J Natl Cancer Inst. 2015;107(9):1–7.
Article
CAS
Google Scholar
Anderson WF, Pfeiffer RM, Wohlfahrt J, Ejlertsen B, Jensen MB, Kroman N. Associations of parity-related reproductive histories with ER± and HER2± receptor-specific breast cancer aetiology [Int J Epidemiol, 46, 1 (2016) (86-95)] DOI:https://doi.org/10.1093/ije/dyw286. Int J Epidemiol. 2017;46(1):373.
Fortner RT, Sisti J, Chai B, Collins LC, Rosner B, Hankinson SE, et al. Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses’ Health Studies. Breast Cancer Res. 2019;21(1):40.
Article
Google Scholar
Abubakar M, Sung H, Devi B, Guida J, Tang T, Pfeiffer R, et al. Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: Analysis of 3012 women from an indigenous Asian population. Breast Cancer Res. 2018;20(1):1–14.
Article
Google Scholar
Chatterjee, Nimrat Walker G. Pooled analysis of nine cohorts reveals breast cancer risk factors by tumor molecular subtype. Physiol Behav [Internet]. 2017;176(10):139–48. Available from: file:///C:/Users/Carla Carolina/Desktop/Artigos para acrescentar na qualificação/The impact of birth weight on cardiovascular disease risk in the.pdf
Chen L, Li CI, Tang M-TC, Porter P, Hill DA, Wiggins CL, et al. Reproductive factors and risk of luminal, HER2-overexpressing, and triple-negative breast cancer among multiethnic women. Cancer Epidemiol Biomarkers Prev. 2016;25(9):1297–304.
Article
CAS
Google Scholar
Ma H, Bernstein L, Pike MC, Ursin G. Reproductive factors and breast cancer risk according to joint estrogen and progesterone receptor status: A meta-analysis of epidemiological studies. Breast Cancer Res [Internet]. 2006 [cited 2020 Dec 17];8(4). Available from: https://pubmed.ncbi.nlm.nih.gov/16859501/
Islami F, Liu Y, Jemal A, Zhou J, Weiderpass E, Colditz G, et al. Breastfeeding and breast cancer risk by receptor status—a systematic review and meta-analysis. Ann Oncol. 2015;26(12):2398–407.
Article
CAS
Google Scholar
Tan MM, Ho WK, Yoon SY, Mariapun S, Hasan SN, Shin-Chi Lee D, et al. A case-control study of breast cancer risk factors in 7,663 women in Malaysia. PLoS One. 2018;13(9):e0203469.
Article
CAS
Google Scholar
Nindrea RD, Aryandono T, Lazuardi L. Breast cancer risk from modifiable and non-modifiable risk factors among women in Southeast Asia: A meta-analysis. Asian Pacific J Cancer Prev. 2017;18(12):3201–6.
Google Scholar
Ghoncheh M, Pournamdar Z, Salehiniya H. Incidence and mortality and epidemiology of breast cancer in the world. Asian Pacific J Cancer Prev. 2016;17(sup3):43–6.
Article
Google Scholar
Sherman ME, Rimm DL, Yang XR, Chatterjee N, Brinton LA, Lissowska J, et al. Variation in breast cancer hormone receptor and HER2 levels by etiologic factors: A population-based analysis. Int J Cancer [Internet]. 2007 1 [cited 2021 Jan 9];121(5):1079–85. Available from: http://doi.wiley.com/10.1002/ijc.22812